Paolo M. Comoglio

45.8k citations

403 papers · 35.5k indexed · 9 hit papers · h-index 104

Molecular Biology top 0.05%
Hepatology top 0.01%
Oncology top 0.1%
Surgery top 0.2%
Cell Biology top 0.05%

Co-authors: Livio Trusolino Silvia Giordano Luca Tamagnone Carla Boccaccio Maria Flavia Di Renzo Luigi Naldini Andrea Bertotti Alberto Bardelli
Topics: Liver physiology and pathology (195 papers)PI3K/AKT/mTOR signaling in cancer (59 papers)Axon Guidance and Neuronal Signaling (40 papers)
Cited by: Hepatology Immunology and Allergy Oncology
Journals: Nature Cell Proceedings of the National Academy of Sciences
Partner nations: Italy United States Belarus

In The Last Decade

Paolo M. Comoglio

399 papers receiving 34.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.

1992 1.2k citations Maria Flavia Di Renzo, Martina Olivero et al. profile →
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

2003 1.1k citations Selma Pennacchietti, Paolo Michieli et al. profile →
MET signalling: principles and functions in development, organ regeneration and cancer

2010 975 citations Livio Trusolino, Andrea Bertotti et al. profile →
Plexins Are a Large Family of Receptors for Transmembrane, Secreted, and GPI-Anchored Semaphorins in Vertebrates

1999 950 citations Luca Tamagnone, Paolo M. Comoglio et al. profile →
A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

1994 839 citations Alberto Bardelli, Silvia Giordano et al. profile →
Drug development of MET inhibitors: targeting oncogene addiction and expedience

2008 674 citations Paolo M. Comoglio, Silvia Giordano et al. profile →
Scatter-factor and semaphorin receptors: cell signalling for invasive growth

2002 624 citations Livio Trusolino, Paolo M. Comoglio profile →
Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.

1991 622 citations Luigi Naldini, Elisa Vigna et al. profile →
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.

1992 484 citations Luigi Naldini, Luca Tamagnone et al. profile →

Peers

Countries citing papers authored by Paolo M. Comoglio

Since Specialization

Citations

This map shows the geographic impact of Paolo M. Comoglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo M. Comoglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo M. Comoglio more than expected).

Fields of papers citing papers by Paolo M. Comoglio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo M. Comoglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo M. Comoglio. The network helps show where Paolo M. Comoglio may publish in the future.

Co-authorship network of co-authors of Paolo M. Comoglio

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo M. Comoglio. A scholar is included among the top collaborators of Paolo M. Comoglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo M. Comoglio. Paolo M. Comoglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary 2023 ·EMBO Molecular Medicine ·(unknown),Virginia Napolitano,(unknown),(unknown),(unknown),(unknown),Eliano Cascardi,Federica Verginelli,(unknown),Gennaro Gambardella,Alberto Pisacane,Alessandro Arcovito,Carla Boccaccio,Paolo M. Comoglio,Enrico Giraudo,Luca Tamagnone	6
2	Activation of the MET receptor attenuates doxorubicin‐induced cardiotoxicity in vivo and in vitro 2020 ·British Journal of Pharmacology ·Simona Gallo,(unknown),Raffaella Albano,Giuseppe Ferrauto,Enza Di Gregorio,Elena Casanova,Davide Balmativola,Alessandro Bonzano,Carla Boccaccio,Anna Sapino,Paolo M. Comoglio,Tiziana Crepaldi	19
3	A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem–Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy 2017 ·Clinical Cancer Research ·Paolo Luraghi,(unknown),(unknown),Gigliola Reato,Francesca Orzan,Francesco Sassi,Francesca De Bacco,Claudio Isella,Sara E. Bellomo,Enzo Médico,Paolo M. Comoglio,Andrea Bertotti,Livio Trusolino,Carla Boccaccio	18
4	Rebound Effects Caused by Withdrawal of MET Kinase Inhibitor Are Quenched by a MET Therapeutic Antibody 2016 ·Cancer Research ·Emanuela Pupo,(unknown),Barbara Lupo,Elisa Vigna,Daniele Avanzato,Timothy Perera,Livio Trusolino,Letizia Lanzetti,Paolo M. Comoglio	20
5	MET Signaling in Colon Cancer Stem-like Cells Blunts the Therapeutic Response to EGFR Inhibitors 2014 ·Cancer Research ·Paolo Luraghi,Gigliola Reato,(unknown),Francesco Sassi,Francesca Orzan,(unknown),Francesca De Bacco,Elena Menietti,May Han,William M. Rideout,Timothy Perera,Andrea Bertotti,Livio Trusolino,Paolo M. Comoglio,Carla Boccaccio	117
6	Microenvironment-Derived HGF Overcomes Genetically Determined Sensitivity to Anti-MET Drugs 2014 ·Cancer Research ·Selma Pennacchietti,(unknown),Andrea Bertotti,William M. Rideout,May Han,Jenő Gyuris,Timothy Perera,Paolo M. Comoglio,Livio Trusolino,Paolo Michieli	55
7	S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab 2013 ·Molecular Cancer Therapeutics ·Mike F. Burbridge,Céline Bossard,(unknown),Imre Fejes,Alain Bruno,Stéphane Léonce,Gilles Ferry,Georges Da Violante,François Bouzom,Valérie Cattan,(unknown),Paolo M. Comoglio,Brian Lockhart,Jean A. Boutin,Alex Cordi,(unknown),Alain St. Pierre,John A. Hickman,Francisco Cruzalegui,Stéphane Depil	74
8	The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype 2012 ·Cancer Research ·Francesca De Bacco,Elena Casanova,Enzo Médico,Serena Pellegatta,Francesca Orzan,Raffaella Albano,Paolo Luraghi,Gigliola Reato,Antonio D’Ambrosio,Paola Porrati,Monica Patanè,Emanuela Maderna,Bianca Pollo,Paolo M. Comoglio,Gaetano Finocchiaro,Carla Boccaccio	111
9	Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas 2012 ·Clinical Cancer Research ·Giorgia Migliardi,Francesco Sassi,Davide Torti,Francesco Galimi,Eugenia R. Zanella,Michela Buscarino,Dario Ribero,Andrea Muratore,Paolo Massucco,Alberto Pisacane,Mauro Risio,Lorenzo Capussotti,Silvia Marsoni,Federica Di Nicolantonio,Alberto Bardelli,Paolo M. Comoglio,Livio Trusolino,Andrea Bertotti	147
10	MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer 2011 ·Clinical Cancer Research ·Cristina Migliore,Valentina Martín,Vera P. Leoni,Angelo Restivo,Luigi Atzori,Annalisa Petrelli,Claudio Isella,Luigi Zorcolo,Ivana Sarotto,G. Casula,Paolo M. Comoglio,Amedeo Columbano,Silvia Giordano	98
11	Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis 2011 ·Cancer Research ·Alessandra Gentile,Luca Lazzari,Silvia Benvenuti,Livio Trusolino,Paolo M. Comoglio	107
12	Ron Kinase Transphosphorylation Sustains MET Oncogene Addiction 2011 ·Cancer Research ·Silvia Benvenuti,Luca Lazzari,(unknown),(unknown),Alessandra Gentile,Paolo M. Comoglio	63
13	MET and KRAS Gene Amplification Mediates Acquired Resistance to MET Tyrosine Kinase Inhibitors 2010 ·Cancer Research ·Virna Cepero,J. Rafael Sierra,Simona Corso,Elena Ghiso,Laura Casorzo,Tim Perera,Paolo M. Comoglio,Silvia Giordano	141
14	MicroRNAs Impair MET-Mediated Invasive Growth 2008 ·Cancer Research ·Cristina Migliore,Annalisa Petrelli,Elena Ghiso,Simona Corso,Lorena Capparuccia,Adriana Eramo,Paolo M. Comoglio,Silvia Giordano	146
15	“Active” Cancer Immunotherapy by Anti-Met Antibody Gene Transfer 2008 ·Cancer Research ·Elisa Vigna,Giovanni Pacchiana,Massimiliano Mazzone,Cristina Chiriaco,(unknown),Cristina Basilico,Selma Pennacchietti,Paolo M. Comoglio	32
16	MET Overexpression Turns Human Primary Osteoblasts into Osteosarcomas 2006 ·Cancer Research ·Salvatore Patanè,Sofia Avnet,Nadia Coltella,Barbara Costa,(unknown),Martina Olivero,Elisa Vigna,Luigi Naldini,Nicola Baldini,Riccardo Ferracini,Simona Corso,Silvia Giordano,Paolo M. Comoglio,Maria Flavia Di Renzo	104
17	Proteolytic Processing Converts the Repelling Signal Sema3E into an Inducer of Invasive Growth and Lung Metastasis 2005 ·Cancer Research ·Claus Christensen,Noona Ambartsumian,Giorgio F. Gilestro,Birthe Lykke Thomsen,Paolo M. Comoglio,Luca Tamagnone,Per Guldberg,Eugene Lukanidin	91
18	β4 Integrin Is a Transforming Molecule that Unleashes Met Tyrosine Kinase Tumorigenesis 2005 ·Cancer Research ·Andrea Bertotti,Paolo M. Comoglio,Livio Trusolino	63
19	C-Terminal Truncated Forms of Met, the Hepatocyte Growth Factor Receptor 1991 ·Molecular and Cellular Biology ·María Prat,Tiziana Crepaldi,Lucia Gandino,Silvia Giordano,Paola Longati,Paolo M. Comoglio	52
20	Receptor for Bombesin with Associated Tyrosine Kinase Activity 1986 ·Molecular and Cellular Biology ·Daniela María Cirillo,Giovanni Gaudino,Luigi Naldini,Paolo M. Comoglio	15

About Paolo M. Comoglio

Paolo M. Comoglio is a scholar working on Hepatology, Immunology and Allergy and Molecular Biology, having authored 403 papers that have together received 35.5k indexed citations. Recurring topics across this work include Liver physiology and pathology (195 papers), PI3K/AKT/mTOR signaling in cancer (59 papers) and Axon Guidance and Neuronal Signaling (40 papers). The work is most often cited by research in Hepatology (13.9k citations), Immunology and Allergy (2.1k citations) and Oncology (8.5k citations). Paolo M. Comoglio has collaborated with scholars based in Italy, United States and Belarus. Frequent co-authors include Livio Trusolino, Silvia Giordano, Luca Tamagnone, Carla Boccaccio, Maria Flavia Di Renzo, Luigi Naldini, Andrea Bertotti, Alberto Bardelli, María Prat and Giovanni Gaudino. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact